Capital Research Global Investors’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53M Buy
912,688
+69,710
+8% +$3.78M 0.01% 353
2025
Q4
$38.9M Hold
842,978
0.01% 364
2025
Q3
$30.4M Sell
842,978
-3,928,808
-82% -$130M 0.01% 383
2025
Q2
$155M Sell
4,771,786
-1,338,322
-22% -$43.9M 0.03% 250
2025
Q1
$231M Sell
6,110,108
-100,415
-2% -$8.03M 0.05% 206
2024
Q4
$508M Buy
6,210,523
+1,312,302
+27% +$130M 0.1% 142
2024
Q3
$560M Buy
4,898,221
+764,677
+18% +$68.9M 0.12% 134
2024
Q2
$312M Sell
4,133,544
-6,977
-0.2% -$475K 0.07% 174
2024
Q1
$283M Buy
4,140,521
+700,414
+20% +$48.5M 0.06% 200
2023
Q4
$216M Buy
3,440,107
+75,980
+2% +$3.95M 0.05% 222
2023
Q3
$172M Hold
3,364,127
0.05% 243
2023
Q2
$168M Buy
3,364,127
+511,121
+18% +$24.2M 0.05% 249
2023
Q1
$107M Buy
2,853,006
+47,004
+2% +$1.99M 0.03% 271
2022
Q4
$135M Buy
2,806,002
+2,291,146
+445% +$89.9M 0.04% 251
2022
Q3
$12.7M Buy
+514,856
New +$13.1M ﹤0.01% 380

Other funds holding PCVX